<DOC>
	<DOCNO>NCT02671266</DOCNO>
	<brief_summary>The purpose current study investigate effect acute administration intranasal oxytocin , relative placebo , social cognitive impairment among individual body dysmorphic disorder obsessive-compulsive disorder , compare healthy control .</brief_summary>
	<brief_title>Oxytocin Administration BDD OCD</brief_title>
	<detailed_description>Despite development efficacious pharmacologic psychological treatment body dysmorphic disorder ( BDD ) , treatment outcome data suggest still considerable room improvement . A close examination biological mechanism underlie psychopathology may help uncover mechanism target intervention thereby provide novel approach treatment . Given neuropeptide , oxytocin , involve regulation variety social cognitive dimension , include emotion recognition social attentional processing , direct implication regard role development deficit among individual BDD . The current study therefore aim investigate effect oxytocin administration social cognitive impairment BDD relate disorder , OCD . Twenty treatment-seeking male female outpatient BDD , 20 individual OCD , 20 healthy participant assign receive oxytocin placebo nasal spray one week apart . During visit , subject complete series task measure emotion recognition , attentional bias , interpretive bias , trust behavior . Importantly , finding may show single administration oxytocin may alter social cognitive process think maintain BDD , ultimately inform treatment BDD .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Compulsive Personality Disorder</mesh_term>
	<mesh_term>Obsessive-Compulsive Disorder</mesh_term>
	<mesh_term>Compulsive Behavior</mesh_term>
	<mesh_term>Body Dysmorphic Disorders</mesh_term>
	<mesh_term>Oxytocin</mesh_term>
	<criteria>Treatmentseeking adult male female ≥ 18 year age Meets DSMIV criterion principal BDD ( BDD group ) principal OCD ( OCD group ) , determine Structured Clinical Interview DSMIV ( SCID ) diagnostic interview For female : must take lowdose oral contraceptive pill , define monophasic pill contain &lt; 50 mcg ethinyl estradiol For healthy volunteer : meet current DSMIV diagnosis Axis I disorder Participants BDD group exclude comorbid diagnosis OCD participant OCD group exclude comorbid diagnosis BDD . Current diagnosis schizophrenia , psychotic disorder , bipolar disorder , substance abuse substance dependence . All Axis I comorbidities permit foster accrual clinically relevant sample . Significant nasal pathology ( e.g. , atrophic rhinitis , history hypophysectomy , recurrent nosebleed ) Smokers smoke ≥ 15 cigarette daily Serious medical illness Active homicidal suicidal ideation Concurrent use psychotropic medication Steroid hormone use ( except lowdose oral contraceptive pill female , allow ) For female : positive urine pregnancy test use high dose estrogen/progestin pill ( low dose estrogen/progestin oral contraceptive allow due stability hormone level active phase ) For healthy volunteer : current DSMIV Axis I disorder</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Oxytocin</keyword>
	<keyword>Body dysmorphic disorder</keyword>
	<keyword>Obsessive-compulsive disorder</keyword>
</DOC>